AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
CIM

Chimera Investment Corporation Common Stock (CIM) fair value

Real Estate · REIT - Mortgage · NYSE · United States
$8.42-0.36%
Market cap $705MNext earnings 2026-11-05Updated Oct 24, 2026
Add earnings to calendarGoogle
Our verdict
Trades 76% below our fair value
Price
$8.42
Model fair valueConfidence: low
about $34.59
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a REIT (property company): Price to FFO.
ACCE opinionChimera Investment Corporation Common Stock (CIM)
Fair value (2 models)
Not available
ACCE price target
$9.40
Rating
Not rated
Horizon
12 months
ACCE price target published on 14 Oct 2026, 00:00 CEST.
Price used: $8.42 at the close on 23 Oct 2026, 22:00 CEST.
Models: Price to FFO.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
37
out of 100
Analysts
20% buy
5 covering
1-year return
-34.9%
Dividend yield
21.30%

Chimera Investment Corporation Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Chimera Investment Corporation is a mortgage REIT that invests mainly in non-agency residential mortgage loans and securities, financing them with repurchase agreements and earning the spread between asset yields and borrowing costs. Its edge is in credit selection and loan-level underwriting of non-agency paper, a niche where the book value depends more on how well loans are picked than on interest rate direction. Revenue grew 8.1% and the stock trades at a forward P/E of 5.3, but ROE of 0.1% and a trailing P/E of 0.0 show that reported earnings have barely reached shareholders, so the discount reflects balance-sheet and spread risk rather than an obvious mispricing. The score of 37/100 and absence from any index suggest the name is under-owned and sentiment-driven, which makes it a candidate for a deeper look at book value trends, funding costs and dividend coverage before any position is considered.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • severe
    Negative free cash flow
    Free cash flow is $-248,879,000 against a $679M market cap, with debt/equity at 5.08. Cash burn at this scale is a serious capital structure concern.
  • high
    Earnings collapsing despite revenue growth
    Net margin of 0.5% and ROE of 0.1% leave almost no cushion.
  • moderate
    Score weak on margins
    The margin sub-score is 17/100, the lowest of the four components, and the overall ACCE score is 37/100.

AI research notes

AI-assisted·How I use AIWritten Oct 20, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Revenue grew 8.1% over the last year, and the five-year average annual growth rate is 29.1%.
  • Analysts' mean price target of $14.17 sits 74.5% above the current share price.
Why it could disappoint
  • The 19.5% dividend yield is paid from thin earnings, with a net margin of only 0.5% and return on equity of 0.1%.
  • Free cash flow over the last twelve months was negative at -$249M, and debt is 5.08 times equity.
  • The latest quarter missed expectations, with earnings per share of 0.46 against 0.52 expected, a 11.5% shortfall.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 5, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where CIM's valuation models land
Price
$8.42
Model fair valueConfidence: low
about $34.59
Model
Fair value
Upside
Price to FFO
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bearish20% buy · 5 covering analysts
● Strong buy 1● Buy 0● Hold 4● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+0.2%
1 month
-21.7%
3 months
-32.6%
6 months
-38.0%
YTD
-32.3%
1 year
-34.9%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
17 Oct 2026, 00:00 CESTFair value$19.57$18.74$8.55
14 Oct 2026, 00:00 CESTACCE price target$9.40first publication$8.76
12 Oct 2026, 00:00 CESTFair value$18.74$9.06$8.96
8 Oct 2026, 00:00 CESTFair value$9.06first publication$9.20

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full CIM page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth40Value40Quality49Momentum17Total37
Valuation
Trailing P/E
no data
Forward P/E
4.1x
PEG
no data
P/B
0.39x
EV / Revenue
66.9x
Book value/sh
$28.85
Enterprise value
$13.7B
Profitability
ROE
0.1%
FCF yield
-35.31%
ROIC
1.2%
Health and risk
Debt / equity
5.08
Dividend yield
21.30%
Beta
1.81

Price

-35.5% · 1Y

Ask anything about CIM

Answered from Chimera Investment Corporation Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
ROEbetter than 0% of peers
low 0%0%high 16%
Div yieldbetter than 33% of peers
low 12.9%21.3%high 32.4%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
CIM Chimera Investment Corporation Common Stock$8.42---0.1%4937
ADAM Adamas Trust Inc. Common Stock$7.81$1338% below4.6x16.4%7273
MFA MFA Financial Inc.$6.66--6.6x8.2%6763
IVR INVESCO MORTGAGE CAPITAL INC Common Stock$5.54--3.6x14.1%7265
ARI Apollo Commercial Real Estate Finance Inc$6.42$1248% below8.0x8.5%6753
PMT PennyMac Mortgage Investment Trust Common Shares of Beneficial Interest$7.04--4.7x8.9%5956
ABR Arbor Realty Trust Common Stock$2.92--32.9x2.0%3932

Sector report card

Where CIM ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Sep 17, 2026
    Chimera Declares $0.45 Per Share Third Quarter 2026 Common Stock Dividend
  • Business Wire•Aug 5, 2026
    CHIMERA INVESTMENT CORPORATION'S SECOND QUARTER EARNINGS MAINTAIN SUPPORT FOR $0.45 DIVIDEND
  • Business Wire•Aug 5, 2026
    Chimera Declares Third Quarter 2026 Preferred Stock Dividends
6 more press releases · full archive on Investor+.INVESTOR
37 filings of 40
September 2026
Sep 17
8-KCurrent reportPeriod 2026-09-17
View on SEC →
August 2026
Aug 5
8-KCurrent reportPeriod 2026-08-05
View on SEC →
Aug 5
8-KCurrent reportPeriod 2026-08-05
View on SEC →
34 more filings + AI summaries on Investor+.INVESTOR